Literature DB >> 30089701

Distinctive Roles for Type I and Type II Interferons and Interferon Regulatory Factors in the Host Cell Defense against Varicella-Zoster Virus.

Nandini Sen1, Phillip Sung1, Arjun Panda2, Ann M Arvin3,4.   

Abstract

Both type I and type II interferons (IFNs) have been implicated in the host defense against varicella-zoster virus (VZV), a common human herpesvirus that causes varicella and zoster. The purpose of this study was to compare their contributions to the control of VZV replication, to identify the signaling pathways that are critical for mediating their antiviral activity, and to define the mechanisms by which the virus counteracts their effects. Gamma interferon (IFN-γ) was much more potent than IFN-α in blocking VZV infection, which was associated with a differential induction of the interferon regulatory factor (IRF) proteins IRF1 and IRF9, respectively. These observations account for the clinical experience that while the formation of VZV skin lesions is initially controlled by local immunity, adaptive virus-specific T cell responses are required to prevent life-threatening VZV infections.IMPORTANCE While both type I and type II IFNs are involved in the control of herpesvirus infections in the human host, to our knowledge, their relative contributions to the restriction of viral replication and spread have not been assessed. We report that IFN-γ has more potent activity than IFN-α against VZV. Findings from this comparative analysis show that the IFN-α-IRF9 axis functions as a first line of defense to delay the onset of viral replication and spread, whereas the IFN-γ-IRF1 axis has the capacity to block the infectious process. Our findings underscore the importance of IRFs in IFN regulation of herpesvirus infection and account for the clinical experience of the initial control of VZV skin infection attributable to IFN-α production, together with the requirement for induction of adaptive IFN-γ-producing VZV-specific T cells to resolve the infection.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  IRF1 mediates the inhibitory effects of interferon gamma on VZV; IRF9 mediates the action of interferon alpha on VZV; VZV innate immune control; interferon alpha delays onset of VZV spread; interferon gamma abrogates VZV replication

Mesh:

Substances:

Year:  2018        PMID: 30089701      PMCID: PMC6189497          DOI: 10.1128/JVI.01151-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

Review 1.  IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.

Authors:  Kenya Honda; Tadatsugu Taniguchi
Journal:  Nat Rev Immunol       Date:  2006-09       Impact factor: 53.106

2.  Analysis of T cell responses during active varicella-zoster virus reactivation in human ganglia.

Authors:  Megan Steain; Jeremy P Sutherland; Michael Rodriguez; Anthony L Cunningham; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

3.  Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5.

Authors:  Qinglin Li; Robert Means; Sabine Lang; Jae U Jung
Journal:  J Virol       Date:  2006-12-13       Impact factor: 5.103

4.  limma powers differential expression analyses for RNA-sequencing and microarray studies.

Authors:  Matthew E Ritchie; Belinda Phipson; Di Wu; Yifang Hu; Charity W Law; Wei Shi; Gordon K Smyth
Journal:  Nucleic Acids Res       Date:  2015-01-20       Impact factor: 16.971

5.  A scaling normalization method for differential expression analysis of RNA-seq data.

Authors:  Mark D Robinson; Alicia Oshlack
Journal:  Genome Biol       Date:  2010-03-02       Impact factor: 13.583

6.  Role for herpes simplex virus 1 ICP27 in the inhibition of type I interferon signaling.

Authors:  Karen E Johnson; Byeongwoon Song; David M Knipe
Journal:  Virology       Date:  2008-02-14       Impact factor: 3.616

7.  STAT2 nuclear trafficking.

Authors:  Gregg Banninger; Nancy C Reich
Journal:  J Biol Chem       Date:  2004-06-01       Impact factor: 5.157

8.  voom: Precision weights unlock linear model analysis tools for RNA-seq read counts.

Authors:  Charity W Law; Yunshun Chen; Wei Shi; Gordon K Smyth
Journal:  Genome Biol       Date:  2014-02-03       Impact factor: 13.583

9.  Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha.

Authors:  Chia-Chi Ku; Leigh Zerboni; Hideki Ito; Brad S Graham; Mark Wallace; Ann M Arvin
Journal:  J Exp Med       Date:  2004-09-27       Impact factor: 14.307

10.  IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage.

Authors:  HyeonJoo Cheon; Elise G Holvey-Bates; John W Schoggins; Samuel Forster; Paul Hertzog; Naoko Imanaka; Charles M Rice; Mark W Jackson; Damian J Junk; George R Stark
Journal:  EMBO J       Date:  2013-09-24       Impact factor: 11.598

View more
  12 in total

1.  Varicella-zoster virus: molecular controls of cell fusion-dependent pathogenesis.

Authors:  Stefan L Oliver; Momei Zhou; Ann M Arvin
Journal:  Biochem Soc Trans       Date:  2020-12-18       Impact factor: 5.407

2.  Interferon Gamma Inhibits Varicella-Zoster Virus Replication in a Cell Line-Dependent Manner.

Authors:  Akhalesh K Shakya; Seong K Kim; Dennis J O'Callaghan
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

3.  Insights into the pathogenesis of varicella viruses.

Authors:  Océane Sorel; Ilhem Messaoudi
Journal:  Curr Clin Microbiol Rep       Date:  2019-07-06

4.  Tofacitinib downregulates antiviral immune defence in keratinocytes and reduces T cell activation.

Authors:  Heike C Hawerkamp; Alina Domdey; Lisa Radau; Philipp Sewerin; Péter Oláh; Bernhard Homey; Stephan Meller
Journal:  Arthritis Res Ther       Date:  2021-05-21       Impact factor: 5.156

Review 5.  COVID-19 Drug Treatment in China.

Authors:  Linzi Fan; Shuang Jiang; Xinrong Yang; Zhibin Wang; Chunjuan Yang
Journal:  Curr Pharmacol Rep       Date:  2020-09-07

Review 6.  Determinants of neurological syndromes caused by varicella zoster virus (VZV).

Authors:  Peter Ge Kennedy; Trine H Mogensen
Journal:  J Neurovirol       Date:  2020-06-03       Impact factor: 2.643

7.  Functional paralysis of human natural killer cells by alphaherpesviruses.

Authors:  Tessa Mollie Campbell; Brian Patrick McSharry; Megan Steain; Tiffany Ann Russell; David Carl Tscharke; Jarrod John Kennedy; Barry Slobedman; Allison Abendroth
Journal:  PLoS Pathog       Date:  2019-06-13       Impact factor: 6.823

Review 8.  Manipulation of the Innate Immune Response by Varicella Zoster Virus.

Authors:  Chelsea Gerada; Tessa M Campbell; Jarrod J Kennedy; Brian P McSharry; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  Front Immunol       Date:  2020-01-24       Impact factor: 7.561

Review 9.  Skin Viral Infections: Host Antiviral Innate Immunity and Viral Immune Evasion.

Authors:  Vivian Lei; Amy J Petty; Amber R Atwater; Sarah A Wolfe; Amanda S MacLeod
Journal:  Front Immunol       Date:  2020-11-06       Impact factor: 7.561

10.  Human Metapneumovirus Induces IRF1 via TANK-Binding Kinase 1 and Type I IFN.

Authors:  Simon Loevenich; Alix S Spahn; Kristin Rian; Victor Boyartchuk; Marit Walbye Anthonsen
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.